know more, do more

Advancing endocrinology and improving public health

Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field. 

the latest
EBR 2024
Meetings & Events

Reasons To Choose EBR 2024 for Your Certification Journey

July 17, 2024

Designed for fellows, practicing endocrinologists, and healthcare professionals, EBR 2024 ensures you are well-prepared for board certification. The program guarantees a pass or offers free registration for EBR 2025. Participants receive the Endocrine Board Review (EBR) 2024 16th Edition book, access to interactive practice exams, and expert-led Q&A sessions. The preparation covers clinical scenarios aligned with the ABIM exam blueprint. Register by Monday, August 5, to secure the best rates.

ENDO 2025
Meetings & Events

Deadline for ENDO 2025 Session Suggestions

June 18, 2024

Share your preferences for symposium proposals or session suggestions. Even partial ideas will be further developed by our Annual Meeting Steering Committee. We are accepting ideas through Thursday, July 25.

Meetings & Events

Learn How Artificial Intelligence Can Improve Your Practice

June 12, 2024

Our new AI in Healthcare Virtual Summit, taking place online November 8-9, will inform providers, healthcare professionals, researchers, technologists, industry stakeholders, and educators on the capabilities of AI in the healthcare field. Learn from experts how AI technologies are redefining diagnostics, treatment planning, and patient outcomes in healthcare in addition to exploring the latest advancements in AI-driven healthcare, from predictive analytics to machine learning algorithms. Register by Saturday, August 31 to take advantage of our best available rates.

Meetings & Events

Don't Miss the 1st International Conference on Steroid Hormones and Receptors

June 12, 2024

The 1st International Conference on Steroid Hormones and Receptors (SHR 2024) will be held from October 16-18, in Albuquerque, NM, at the University of New Mexico Comprehensive Cancer Center. Join meeting chairs Eric Prossnitz (University of New Mexico) and Endocrine Society incoming President Carol Lange (University of Minnesota) for an innovative agenda covering advances in steroid hormone action in biology and medicine, exploring their role in biology, chemistry, pharmacology, oncology, neurology, metabolism, cardiovascular biology and endocrinology. Learn more and register today.


Advocacy in Action

July 19, 2024

The US House of Representatives will vote on the appropriations bill responsible for funding the NIH, CDC, and other health agencies. We need your voice to strengthen our message about the harms of this bill.

We Are Endocrinology

Deena Adimoolam
“I use media to share a message of prevention and recognition of many endocrine diseases, especially diabetes and obesity. As a member of the Endocrine Society, I have also had the opportunity to continue this work with Society members who share in my vision and passion. I work closely with the Endocrine Society’s Hormone Health Network to spread awareness on various endocrine diseases through patient education tools and media.” – Deena Adimoolam, MD
We are an 18,000 member strong global community
A champion for the Society’s guidelines, Chris has been passionate about improving our guideline development methodology as well as about making guideline content more accessible to readers around the world. – Christopher McCartney, MD

Advantages of Membership

Need more info?

Learn more about the advantages of membership

Endocrine Society News

Endocrine Society urges passage of the Right to IVF Act

June 11, 2024

The Endocrine Society endorses the Right to IVF Act, which was introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA) and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF), and urges the Senate to pass the Right to IVF Act on June 12th to ensure that the freedom to start and grow a family is protected and accessible to everyone in the United States.

Endocrine Society Guideline recommends healthy adults under the age of 75 take the recommended daily allowance of vitamin D

June 03, 2024

Healthy adults under the age of 75 are unlikely to benefit from taking more than the daily intake of vitamin D recommended by the Institutes of Medicine (IOM) and do not require testing for vitamin D levels, according to a new Clinical Practice Guideline issued today by the Endocrine Society. For children, pregnant people, adults older than 75 years and adults with high-risk prediabetes, the guideline recommends vitamin D higher than the IOM recommended daily allowance.

Telemedicine may increase endocrinology care access for under-resourced patients with diabetes and heart disease

June 03, 2024

Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according to a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

View More

Featured Journal Articles

Prolonged Adrenal Insufficiency After Osilodrostat Exposure With Eventual Recovery of Adrenal Function

July 16, 2024

The authors present a 41-year-old woman treated with osilodrostat (an 11β-hydroxylase inhibitor) for persistent hypercortisolism following pituitary surgery and targeted radiation therapy.

The Pattern of GH Action in the Mouse Brain

July 16, 2024

The objective of the present study is to investigate the transport of growth hormone into the mouse brain using histological and pharmacological approaches.

Role of ERα and Aromatase in Juvenile Gigantomastia

July 16, 2024

This study seeks to conduct extensive clinical, biochemical, immunochemical, and genetic studies in three patients with juvenile gigantomastia to determine causative biologic factors.

View More
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.